Mitochondrial transfer in hematological malignancies

被引:9
|
作者
Guo, Xiaodong [1 ]
Can, Can [1 ]
Liu, Wancheng [1 ]
Wei, Yihong [1 ]
Yang, Xinyu [1 ]
Liu, Jinting [1 ]
Jia, Hexiao [1 ]
Jia, Wenbo [1 ]
Wu, Hanyang [1 ]
Ma, Daoxin [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Shandong, Peoples R China
关键词
Mitochondrial transfer; Tunneling nanotubes; Extracellular vesicles; Extracellular mitochondria; Hematological malignancies; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; CHRONIC MYELOGENOUS LEUKEMIA; TUNNELING NANOTUBES; EXTRACELLULAR VESICLES; INTERCELLULAR COMMUNICATION; MULTIPLE-MYELOMA; TNT FORMATION; CANCER-CELLS; IN-VITRO;
D O I
10.1186/s40364-023-00529-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mitochondria are energy-generated organelles and take an important part in biological metabolism. Mitochondria could be transferred between cells, which serves as a new intercellular communication. Mitochondrial transfer improves mitochondrial defects, restores the biological functions of recipient cells, and maintains the high metabolic requirements of tumor cells as well as drug resistance. In recent years, it has been reported mitochondrial transfer between cells of bone marrow microenvironment and hematological malignant cells play a critical role in the disease progression and resistance during chemotherapy. In this review, we discuss the patterns and mechanisms on mitochondrial transfer and their engagement in different pathophysiological contexts and outline the latest knowledge on intercellular transport of mitochondria in hematological malignancies. Besides, we briefly outline the drug resistance mechanisms caused by mitochondrial transfer in cells during chemotherapy. Our review demonstrates a theoretical basis for mitochondrial transfer as a prospective therapeutic target to increase the treatment efficiency in hematological malignancies and improve the prognosis of patients.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Cytomegalovirus in hematological malignancies
    Bakhshi, Sameer
    Biswas, Bivas
    INDIAN PEDIATRICS, 2013, 50 (02) : 193 - 194
  • [22] Pregnancy In Hematological Malignancies
    Vinogradova, Maria A.
    Shmakov, Roman G.
    Polushkina, Eugenia S.
    Demina, Elena A.
    BLOOD, 2013, 122 (21)
  • [23] Hematological malignancies: myeloma
    Dimopoulos, M. A.
    Kastritis, E.
    Anagnostopoulos, A.
    ANNALS OF ONCOLOGY, 2006, 17 : X137 - X143
  • [24] Deubiquitinases in hematological malignancies
    Hu Lei
    Jiaqi Wang
    Jiacheng Hu
    Qian Zhu
    Yingli Wu
    Biomarker Research, 9
  • [25] MicroRNAs in hematological malignancies
    Lawrie, Charles H.
    BLOOD REVIEWS, 2013, 27 (03) : 143 - 154
  • [26] THE CYTOGENETICS OF HEMATOLOGICAL MALIGNANCIES
    BERGER, R
    BAILLIERES CLINICAL HAEMATOLOGY, 1992, 5 (04): : 791 - 814
  • [27] FERRITINEMIA IN HEMATOLOGICAL MALIGNANCIES
    SALVATORE, M
    POGLIANI, EM
    COFRANCESCO, E
    CONTE, D
    BRUNELLI, L
    POLLI, EE
    HAEMATOLOGICA, 1984, 69 (01) : 90 - 90
  • [28] Two hematological precursors and their impact on hematological malignancies
    Boddicker, N. J.
    Griffin, R.
    Franke, E. G.
    Achenbach, S.
    Rabe, K.
    Olson, J. E.
    Obrien, D. R.
    Norman, A. D.
    Ma, T.
    Call, T. G.
    Hoel, M.
    Braggio, E.
    Hampel, P. J.
    Hanson, C. A.
    Cerhan, J. R.
    Vachon, C.
    Parikh, S. A.
    Shanafelt, T. D.
    Slager, S. L.
    ANNALS OF ONCOLOGY, 2024, 35 : S602 - S603
  • [29] Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies
    Wattel, E
    Vanrumbeke, M
    Abina, MA
    Cambier, N
    Preudhomme, C
    Haddada, H
    Fenaux, P
    LEUKEMIA, 1996, 10 (01) : 171 - 174
  • [30] Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
    Gaman, Amelia Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)